Analysis of matrix metalloproteinase-9 levels among acute heart failure patients with ACE inhibitor therapy (Dr. Soetomo Regional General Hospital, Surabaya)
Heart disease is a clinical condition characterized by specific signs such as joint inflammation, weakness, and shortness of breath. Left ventricular remodeling can be experienced by patients with heart failure wherein a change in myocyte and nonmyocyte components occurs. One of the biomarkers in he...
Saved in:
Published in | Journal of basic and clinical physiology and pharmacology Vol. 32; no. 4; pp. 447 - 451 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Berlin
Walter de Gruyter GmbH
01.07.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Heart disease is a clinical condition characterized by specific signs such as joint inflammation, weakness, and shortness of breath. Left ventricular remodeling can be experienced by patients with heart failure wherein a change in myocyte and nonmyocyte components occurs. One of the biomarkers in heart disease with myocardial fibrosis is matrix metalloproteinase-9 (MMP-9). Common therapy that is often given to patients with heart failure is ACE inhibitors. This main objective of this research is to investigate the effect of ACE inhibitor therapy on the degrees of MMP-9 as a biomarker among patients with heart disease.This research applied one group pretest–posttest design to analyze the variation in the levels of MMP-9 as a biomarker for heart function. Twenty-three subjects with acute heart disease met that inclusion also exclusion criteria, who were selected using nonrandom sampling. Statistical analysis was conducted to specify the levels of MMP-9 before, after the administration of therapy.The most widely used ACE inhibitor drug was ramipril for 15 patients (65%), and the least used ACE Inhibitor drug was captopril for two patients (9%). Meanwhile, the mean MMP-9 levels before therapy was (1,915.26 pg/mL ± 260.84), and the mean MMP-9 levels after therapy was (1,916.93 pg/mL ± 383.12). The statistical analysis result revealed no significant difference in the degrees of Matrix Metalloproteinase-9 accumulation (p=0.378).There was no significant reduction in the levels of Matrix Metalloproteinase-9 after pretest and posttest. |
---|---|
AbstractList | Heart disease is a clinical condition characterized by specific signs such as joint inflammation, weakness, and shortness of breath. Left ventricular remodeling can be experienced by patients with heart failure wherein a change in myocyte and nonmyocyte components occurs. One of the biomarkers in heart disease with myocardial fibrosis is matrix metalloproteinase-9 (MMP-9). Common therapy that is often given to patients with heart failure is ACE inhibitors. This main objective of this research is to investigate the effect of ACE inhibitor therapy on the degrees of MMP-9 as a biomarker among patients with heart disease.This research applied one group pretest–posttest design to analyze the variation in the levels of MMP-9 as a biomarker for heart function. Twenty-three subjects with acute heart disease met that inclusion also exclusion criteria, who were selected using nonrandom sampling. Statistical analysis was conducted to specify the levels of MMP-9 before, after the administration of therapy.The most widely used ACE inhibitor drug was ramipril for 15 patients (65%), and the least used ACE Inhibitor drug was captopril for two patients (9%). Meanwhile, the mean MMP-9 levels before therapy was (1,915.26 pg/mL ± 260.84), and the mean MMP-9 levels after therapy was (1,916.93 pg/mL ± 383.12). The statistical analysis result revealed no significant difference in the degrees of Matrix Metalloproteinase-9 accumulation (p=0.378).There was no significant reduction in the levels of Matrix Metalloproteinase-9 after pretest and posttest. |
Author | Purbosari, Ira Muh Aminuddin Fatmawati, Umi Zulkarnain, Bambang Zubakti |
Author_xml | – sequence: 1 givenname: Ira surname: Purbosari fullname: Purbosari, Ira – sequence: 2 givenname: Bambang surname: Zulkarnain middlename: Zubakti fullname: Zulkarnain, Bambang Zubakti – sequence: 3 fullname: Muh Aminuddin – sequence: 4 givenname: Umi surname: Fatmawati fullname: Fatmawati, Umi |
BookMark | eNotj0tLw0AUhQepYK1du73gRsHUeWTyWJZaW6EgWF2Xm_SmnZJm4sxE7Y_xvxrQszmLD87jkg0a2xBj14JPhBb64VCUbRtJLnnE40SfsaEUuYi4zJIBG_I0l1GSaX3Bxt4feK84FzrNh-xn2mB98saDreCIwZlvOFLAurats4FMg56iHGr6pNoDHm2zAyy7QLAndAEqNHXnCFoMhprg4cuEPUxnczDN3hQmWAdhTw7bE9w-ugmsLQV7tPBKO2P7clhQ0-Malta3pm--h3XnsMAT3l2x8wprT-N_H7H3p_nbbBmtXhbPs-kqKmUq0iiPRSlzzNMq44XCJFUxaaFQFFvkZdXDTGwVZSpLVM8rrXWRKEpiuaUiKQs1Yjd_uf3nj4582Bxs5_pxfiN1nOqMx0KrX32rcBM |
CitedBy_id | crossref_primary_10_1016_j_dsx_2022_102636 |
ContentType | Journal Article |
Copyright | 2021 Walter de Gruyter GmbH, Berlin/Boston |
Copyright_xml | – notice: 2021 Walter de Gruyter GmbH, Berlin/Boston |
DBID | K9. NAPCQ |
DOI | 10.1515/jbcpp-2020-0465 |
DatabaseName | ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitle | ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2191-0286 |
EndPage | 451 |
GroupedDBID | 0R~ 0~D 4.4 53G 5GY 7RV AAAEU AABBZ AAFPC AAGVJ AAILP AALGR AAOQK AAOWA AAPJK AAQCX AASQH AAXCG ABAOT ABAQN ABFKT ABFQV ABIQR ABJNI ABMIY ABPLS ABRDF ABUVI ABVMU ABWLS ABXMZ ABYBW ACEFL ACGFS ACPMA ACZBO ADDWE ADEQT ADGQD ADGYE ADOZN AEDGQ AEGVQ AEICA AEJTT AEQDQ AERZL AEXIE AFBAA AFBQV AFCXV AFGDO AFQUK AFYRI AGBEV AHMBA AHOVO AHVWV AHXUK AIERV AJATJ AJHHK AKXKS ALIPV ALMA_UNASSIGNED_HOLDINGS ALUKF ALYBR ASYPN BAKPI BBCWN BCIFA CGQUA DBYYV EBS EMOBN F5P HZ~ IY9 K9. KDIRW NAPCQ O9- QD8 RDG SA. SLJYH UK5 WTRAM |
ID | FETCH-LOGICAL-c2717-941c29a97f80b3a6734e513a1bda0cf1c281d3e83863b3af555b63e642deb6cb3 |
ISSN | 0792-6855 |
IngestDate | Fri Sep 13 04:51:58 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2717-941c29a97f80b3a6734e513a1bda0cf1c281d3e83863b3af555b63e642deb6cb3 |
PQID | 2547580415 |
PQPubID | 2031338 |
PageCount | 5 |
ParticipantIDs | proquest_journals_2547580415 |
PublicationCentury | 2000 |
PublicationDate | 2021-07-01 |
PublicationDateYYYYMMDD | 2021-07-01 |
PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin |
PublicationPlace_xml | – name: Berlin |
PublicationTitle | Journal of basic and clinical physiology and pharmacology |
PublicationYear | 2021 |
Publisher | Walter de Gruyter GmbH |
Publisher_xml | – name: Walter de Gruyter GmbH |
SSID | ssj0000491579 |
Score | 2.2735097 |
Snippet | Heart disease is a clinical condition characterized by specific signs such as joint inflammation, weakness, and shortness of breath. Left ventricular... |
SourceID | proquest |
SourceType | Aggregation Database |
StartPage | 447 |
SubjectTerms | Biomarkers Cardiovascular disease Heart failure Statistical analysis |
Title | Analysis of matrix metalloproteinase-9 levels among acute heart failure patients with ACE inhibitor therapy (Dr. Soetomo Regional General Hospital, Surabaya) |
URI | https://www.proquest.com/docview/2547580415/abstract/ |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELVK98IF8SlYFuQDWoHalMaO83EsS7sFLUslWlTtpbJTB8JukqpNBOW_8EO5MXacpKIrBFyiyJacpvNsjydv3iD0jPnSDagtLO5G3HJsQSzOiG-Jvi09EXqcSZU7_O7cHc-ct3M2b7V-7rCWilz0wu_X5pX8j1WhDeyqsmT_wbL1oNAA92BfuIKF4fpXNt5VFEmU1v43VRFafUrX8gtxCluUFXSuFDFoY-oK8VAxA1Qd67wT8Vix0itxVZPpNjgZduL0cyxgsmsKopIdUJ7o63Wv8yGTeZZkYJZPZRDR6FbXBUhKqo9iCmx5FWbYd35h8zRCsXVqpo6xNIpQq0ZTu476T4q1yDa8TI5_s653lIvi6pLD0Kb2PE8Ehze9KAS_zOMGUur7VJwWy2Vcz4gRzxP-lZechlkS7wZBiF0TZs1Sq6kFnSVMrHWxVbeniRjvLKVeQCzXLwWBe1K3wVINwxAjxG32gibW2gQ69MLulLqgxkdwSpHcve2HaaWOLyJcrQCoRBNnWbPTVuyC8_eL0ezsbDEdzqc30AHxAua10cHg9NXwYx0ghKObzUqtyOrXG2kqeMrL356x50lo92h6G90ypsWDEqR3UEumd9HxpDTitounTZ7fpouP8WTHvPfQjwrJOItwiWR8DZJxiWSskYw1krFGMjZIxhWSsUIyBiTjGsnYIBk_Bxxjg2Nc4RgbHOMKx11cofjFfTQbDacnY8sUDrFC4oHXFTh2SAIeeJHfF5S7HnUksym3xZL3wwg64ZRGpU99l0J_xBgTLpVwFF9K4YaCPkDtNEvlQ4RDCZaHASgNicrKFlQ6XhSEnhI5Ii59hI6qP35hVobNgjAHjuFK_OLwz92P0c0GzUeona8L-QSc3Fw8NXD4BfkfsyQ |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Walter de Gruyter |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+matrix+metalloproteinase-9+levels+among+acute+heart+failure+patients+with+ACE+inhibitor+therapy+%28Dr.+Soetomo+Regional+General+Hospital%2C+Surabaya%29&rft.jtitle=Journal+of+basic+and+clinical+physiology+and+pharmacology&rft.au=Purbosari%2C+Ira&rft.au=Zulkarnain%2C+Bambang+Zubakti&rft.au=Muh+Aminuddin&rft.au=Fatmawati%2C+Umi&rft.date=2021-07-01&rft.pub=Walter+de+Gruyter+GmbH&rft.issn=0792-6855&rft.eissn=2191-0286&rft.volume=32&rft.issue=4&rft.spage=447&rft.epage=451&rft_id=info:doi/10.1515%2Fjbcpp-2020-0465&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0792-6855&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0792-6855&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0792-6855&client=summon |